Skip to main content
Top
Published in: Multidisciplinary Respiratory Medicine 1/2019

Open Access 01-12-2019 | Chronic Obstructive Lung Disease | Original research article

Patients’ usability of seven most used dry-powder inhalers in COPD

Authors: Roberto W. Dal Negro, Paola Turco, Massimiliano Povero

Published in: Multidisciplinary Respiratory Medicine | Issue 1/2019

Login to get access

Abstract

Introduction

Inhalation devices affect both the effectiveness and the therapeutic outcomes in persistent airway obstruction, and the effects are largely independent of the drug(s) assumed. Usability is a complex and comprehensive indicator of inhalation devices’ performance. The Global Usability Score (GUS) Questionnaire is an investigational tool designed to assess objectively the patients’-related and unrelated domains of devices’ usability.

Methods

The GUS questionnaire was administered to all consecutive COPD patients referring for three months to the Lung Unit of CEMS Specialist Centre (Verona, Italy). The usability of seven Dry Powder Inhalers (DPIs) indicated as appropriate in COPD was tested and compared: Breezhaler, Diskus, Ellipta, Genuair, Nexthaler, Spiromax, and Turbohaler. Patients were divided in two groups, checked separately, according to their DPIs previous experience. A Bayesian Indirect Comparison (IC) model was built to assess “global usability” ranking.

Results

A total of 103 patients were investigated: 74 patients already instructed in DPI use and 29 naive to DPIs. IC analysis proved Ellipta as the device characterized by the highest usability, while Breezhaler the device with the lowest usability in both groups of COPD patients (both with probability > 90%). Moreover, Turbohaler ranked second according to the Bayesian pooling, followed by Diskus, Spiromax, Nexthaler, and Genuair in patients already instructed in DPI use, while the ranking order was not as much well defined in naïve patients, likely due to their too small sample.

Conclusions

Usability is a multifaceted indicator that contributes to assess the factual DPIs’ convenience in real life. DPIs are characterized by different levels of real-life usability, which can be checked, compared and ranked by means of the GUS score.
Appendix
Available only for authorised users
Literature
1.
go back to reference Virchow JC, Crompton GK, Dal Negro RW, Pedersen S, Magnan A, Seidenberg J, et al. Importance of inhaler devices in the management of airway diseases. Respir Med. 2008;102:10–9.CrossRef Virchow JC, Crompton GK, Dal Negro RW, Pedersen S, Magnan A, Seidenberg J, et al. Importance of inhaler devices in the management of airway diseases. Respir Med. 2008;102:10–9.CrossRef
2.
go back to reference Gustafsson P, Taylor A, Zanen P, Chrystyn H. Can patients use all dry powder inhalers equally well ? Int J Clin Pract Suppl. 2005;149:13–8.CrossRef Gustafsson P, Taylor A, Zanen P, Chrystyn H. Can patients use all dry powder inhalers equally well ? Int J Clin Pract Suppl. 2005;149:13–8.CrossRef
3.
go back to reference Melani AS. Inhalation therapy training: a priority challenge for the physician. Acta Biomed. 2007;78:233–45.PubMed Melani AS. Inhalation therapy training: a priority challenge for the physician. Acta Biomed. 2007;78:233–45.PubMed
4.
go back to reference Newman SP, Busse WW. Evolution of dry powder inhaler design, formulation, and performance. Respir Med. 2002;96:293–304.CrossRef Newman SP, Busse WW. Evolution of dry powder inhaler design, formulation, and performance. Respir Med. 2002;96:293–304.CrossRef
5.
go back to reference Chapman KR, Fogarty CM, Peckitt C, Lassen C, Jadayel D, Dederichs J, et al. Delivery characteristics and patients’ handling of two single-dose dry powder inhalers used in COPD. Int J Chron Obstruct Pulmon Dis. 2011;6:353–6. Chapman KR, Fogarty CM, Peckitt C, Lassen C, Jadayel D, Dederichs J, et al. Delivery characteristics and patients’ handling of two single-dose dry powder inhalers used in COPD. Int J Chron Obstruct Pulmon Dis. 2011;6:353–6.
6.
go back to reference Barrons R, Pegram A, Borrens A. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease. Am J Health Syst Pharm. 2011;68:1221–32.CrossRef Barrons R, Pegram A, Borrens A. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease. Am J Health Syst Pharm. 2011;68:1221–32.CrossRef
7.
go back to reference Chrystyn K. Do patients show the same level of adherence with all powder inhalers? Int J Clin Pract Suppl. 2005;149:19–25.CrossRef Chrystyn K. Do patients show the same level of adherence with all powder inhalers? Int J Clin Pract Suppl. 2005;149:19–25.CrossRef
8.
go back to reference Franks M, Briggs P. Use of a cognitive ergonomics approach to compare usability of a multidose dry powder inhaler and a capsule dry powder inhaler: an open label, randomized, controlled study. Clin Ther. 2004;26:1791–9.CrossRef Franks M, Briggs P. Use of a cognitive ergonomics approach to compare usability of a multidose dry powder inhaler and a capsule dry powder inhaler: an open label, randomized, controlled study. Clin Ther. 2004;26:1791–9.CrossRef
9.
go back to reference Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI Respir Med. 2000;94:496–500.CrossRef Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI Respir Med. 2000;94:496–500.CrossRef
10.
go back to reference Anderson P. Patient preference for and satisfaction with inhaler deviced. Eur Respir Rev. 2005;96:109–16.CrossRef Anderson P. Patient preference for and satisfaction with inhaler deviced. Eur Respir Rev. 2005;96:109–16.CrossRef
11.
go back to reference Perpina Tordera M, Viejo JL, Sanchis J, Badia X, Cobos N, Picado C, et al. Assessment of patient satisfaction and preferences with inhalers in asthma with the FSI-10 questionnaire. Arch Broncopneumol. 2008;44:346–52.CrossRef Perpina Tordera M, Viejo JL, Sanchis J, Badia X, Cobos N, Picado C, et al. Assessment of patient satisfaction and preferences with inhalers in asthma with the FSI-10 questionnaire. Arch Broncopneumol. 2008;44:346–52.CrossRef
12.
go back to reference Schulte M, Osseiran K, Betz R, Wencker M, Brand P, Meyer T, et al. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD. J Aerosol Med Pulm Drug Deliv. 2008;21:321–8.CrossRef Schulte M, Osseiran K, Betz R, Wencker M, Brand P, Meyer T, et al. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD. J Aerosol Med Pulm Drug Deliv. 2008;21:321–8.CrossRef
13.
go back to reference Hodder R, Price D. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat soft mist inhaler. Int J Chron Obstruct Pulmon Dis. 2009;4:381–90.CrossRef Hodder R, Price D. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat soft mist inhaler. Int J Chron Obstruct Pulmon Dis. 2009;4:381–90.CrossRef
14.
go back to reference van der Polen J, Ginko T, Kroker A, van der Valk P, Goosens M, Padullés L, et al. Preference, satisfaction and errors with two dry powder inhalers in patients with COPD. Expert Opin Drug Deliv. 2013;10:1023–31. van der Polen J, Ginko T, Kroker A, van der Valk P, Goosens M, Padullés L, et al. Preference, satisfaction and errors with two dry powder inhalers in patients with COPD. Expert Opin Drug Deliv. 2013;10:1023–31.
15.
go back to reference Hantulik P, Wittig K, Henschel Y, Ochse J, Vahteristo M, Rytila P. Usage and usability of one powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany. Pneumol Alergol Pol. 2015;83:365–77.CrossRef Hantulik P, Wittig K, Henschel Y, Ochse J, Vahteristo M, Rytila P. Usage and usability of one powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany. Pneumol Alergol Pol. 2015;83:365–77.CrossRef
16.
go back to reference Kozma CM, Slaton TL, Monz BU, Hodder R, Reese PR. Development and validation of a patient satisfaction and preference questionnaire for inhalation devices. Treat Respir Med. 2005;4:41–52.CrossRef Kozma CM, Slaton TL, Monz BU, Hodder R, Reese PR. Development and validation of a patient satisfaction and preference questionnaire for inhalation devices. Treat Respir Med. 2005;4:41–52.CrossRef
17.
go back to reference Rajan SK, Gogtay JA. Ease-of-use, preference, confidence, and satisfaction with Revolizer, a novel dry powder inhaler, in an Indian population. Lung India. 2014;31:366–74.CrossRef Rajan SK, Gogtay JA. Ease-of-use, preference, confidence, and satisfaction with Revolizer, a novel dry powder inhaler, in an Indian population. Lung India. 2014;31:366–74.CrossRef
18.
go back to reference Dal Negro RW, Povero M. Usability and cost-of-usability of three dry-powder inhalers (DPIs) in patients with chronic obstructive pulmonary disease (COPD): may these variables influence the health technology assessment of DPIs? Chron Obstruct Pulm Dis. 2016;1:2–12. Dal Negro RW, Povero M. Usability and cost-of-usability of three dry-powder inhalers (DPIs) in patients with chronic obstructive pulmonary disease (COPD): may these variables influence the health technology assessment of DPIs? Chron Obstruct Pulm Dis. 2016;1:2–12.
19.
go back to reference Zervas E, Samitas K, Gaga M. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.Int J Chron Obstruct Pulmon Dis. 2016;11:1845–55. Zervas E, Samitas K, Gaga M. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.Int J Chron Obstruct Pulmon Dis. 2016;11:1845–55.
23.
go back to reference Spiegelhalter DJ, Best NG, Carlin BP, Van der Linde A. Bayesian measures of model complexity and fit. J Royal Stat Soc Series B Stat Methodol. 2002;64:583–639.CrossRef Spiegelhalter DJ, Best NG, Carlin BP, Van der Linde A. Bayesian measures of model complexity and fit. J Royal Stat Soc Series B Stat Methodol. 2002;64:583–639.CrossRef
25.
go back to reference Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000;10:325–37.CrossRef Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000;10:325–37.CrossRef
26.
go back to reference Thomas M, Williams AE. Are outcomes the same with all dry powder inhalers? Int J Clin Pract Suppl. 2005;149:33–5 1; 6–7.CrossRef Thomas M, Williams AE. Are outcomes the same with all dry powder inhalers? Int J Clin Pract Suppl. 2005;149:33–5 1; 6–7.CrossRef
27.
go back to reference Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic airways disease: a systemic review of the literature. Health Technol Assess. 2001;5:1–149.CrossRef Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic airways disease: a systemic review of the literature. Health Technol Assess. 2001;5:1–149.CrossRef
28.
go back to reference Kruger P., Ehrlein B, Zier M, Greguletz R. Inspiratory flow resistance of marketed dry powder inhalers. Oral presentation at the European Respiratory Society Annual Meeting, Munich, Germany, september 6th–10th, 2014, proceedings). Kruger P., Ehrlein B, Zier M, Greguletz R. Inspiratory flow resistance of marketed dry powder inhalers. Oral presentation at the European Respiratory Society Annual Meeting, Munich, Germany, september 6th–10th, 2014, proceedings).
29.
go back to reference Lavorini F, Mannini C, Chellini E, Fontana GA. Optimising inhaled pharmacotherapy for elderly patients with chronic obstructive pulmonary disease: the importance of delivery devices. Drugs Ageing. 2016;33(7):461–73.CrossRef Lavorini F, Mannini C, Chellini E, Fontana GA. Optimising inhaled pharmacotherapy for elderly patients with chronic obstructive pulmonary disease: the importance of delivery devices. Drugs Ageing. 2016;33(7):461–73.CrossRef
30.
go back to reference Suarez-Barcelo M, Micca JL, Clackum S, Ferguson GT. Chronic obstructive pulmonary disease in long-term care setting: current practices, challenges, and unmet needs. Curr Opin Pulm Med. 2017;23(suppl 1):s1–s28.PubMed Suarez-Barcelo M, Micca JL, Clackum S, Ferguson GT. Chronic obstructive pulmonary disease in long-term care setting: current practices, challenges, and unmet needs. Curr Opin Pulm Med. 2017;23(suppl 1):s1–s28.PubMed
31.
go back to reference Dal Negro RW. Dry powder inhalers and the right things to remember: a concept review. Multidiscip Respir Med. 2015;10(1):13.CrossRef Dal Negro RW. Dry powder inhalers and the right things to remember: a concept review. Multidiscip Respir Med. 2015;10(1):13.CrossRef
32.
go back to reference Price D. Do healthcare professionals think that dry powder inhalers can be used interchangeably? Int J Clin Pract Suppl. 2005;149:26–9.CrossRef Price D. Do healthcare professionals think that dry powder inhalers can be used interchangeably? Int J Clin Pract Suppl. 2005;149:26–9.CrossRef
33.
go back to reference Kubus C, Wick JY. Drug-device combinations: are they appropriate for the ageing population? Consult Pharm. 2016;31:240–50.CrossRef Kubus C, Wick JY. Drug-device combinations: are they appropriate for the ageing population? Consult Pharm. 2016;31:240–50.CrossRef
34.
go back to reference Rogliani P, Calzetta L, Coppola A, Cavalli F, Ora J, Puxeddu E, et al. Optimiziong drug delivery in COPD: the role of inhaler devices. Respir Med. 2017;124:6–14.CrossRef Rogliani P, Calzetta L, Coppola A, Cavalli F, Ora J, Puxeddu E, et al. Optimiziong drug delivery in COPD: the role of inhaler devices. Respir Med. 2017;124:6–14.CrossRef
35.
go back to reference Salvi S, Gogtay J, Aggarwal B. Use of breath-actuated inhalers in patients with asthma and COPD an advance in inhalation therapy: a systemic review. Expert Rev Respir Med. 2014;8:89–99.CrossRef Salvi S, Gogtay J, Aggarwal B. Use of breath-actuated inhalers in patients with asthma and COPD an advance in inhalation therapy: a systemic review. Expert Rev Respir Med. 2014;8:89–99.CrossRef
36.
go back to reference DePietro M, Gilbert I, Millette LA, Riebe M. Inhalation device options for the management of chronic obstructive pulmonary disease. Postgrad Med. 2018;130:83–97.CrossRef DePietro M, Gilbert I, Millette LA, Riebe M. Inhalation device options for the management of chronic obstructive pulmonary disease. Postgrad Med. 2018;130:83–97.CrossRef
Metadata
Title
Patients’ usability of seven most used dry-powder inhalers in COPD
Authors
Roberto W. Dal Negro
Paola Turco
Massimiliano Povero
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Multidisciplinary Respiratory Medicine / Issue 1/2019
Electronic ISSN: 2049-6958
DOI
https://doi.org/10.1186/s40248-019-0192-5

Other articles of this Issue 1/2019

Multidisciplinary Respiratory Medicine 1/2019 Go to the issue